Market-first feature leverages mobile and sensor technology via PAREXEL’s ClinPhone® RTSM mobile app to prevent temperature-compromised medication from reaching clinical trial patientsBOSTON, October 27, 2017 - PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced a new feature for its ClinPhone® RTSM (randomization and trial supply management) Mobile App that addresses the workflow and safety issues commonly associated with the packaging, transport, and storage of temperature-sensitive medications. The industry-first capability will provide end-to-end...
Source: RealWire
- View Press Release
|
|
|
